SESN2 and Parkinson disease: ECE caused a dose-dependent downregulation of p53, Sesn2 and phosphorylated AMPK in cells, accompanied by the increased phosphorylated p70S6K, alleviating SH-SY5Y cell damage and exhibiting neuroprotective effects in PD.